(-) - - 赛林加瑞诺醇通过改善肠道上皮质屏障功能和抑制炎症反应来减轻性结肠炎
Yunhe Liu1, Junzhe Wu1, Luying Tan1
1School of Pharmaceutical Sciences, Jilin University, Changchun, Jilin 130021, China.
(-) - - 西林加瑞诺 (SYR) 通过加强肠道屏障和减少炎症,有效治疗性结肠炎 (UC). 这种天然的原体显示出作为UC治疗剂的潜力.
科学领域:
- 自然产品化学 自然产品化学
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
背景情况:
- (-) -Syringaresinol (SYR) 是一种具有已知的抗氧化和抗炎性质的灵,已经证明了各种药理上的益处.
- 虽然它在性结肠炎 (UC) 中的反抗体的疗效已经确立,但SYR在UC中的直接作用和机制仍然不清楚.
研究的目的:
- 调查SYR对UC的保护作用.
- 阐明SYR在UC中的作用的潜在分子机制.
主要方法:
- 对SYR对肠上皮质屏障功能和炎症反应的影响使用脂多糖 (LPS) 诱导的Caco-2细胞和硫酸 (DSS) 诱导的UC小鼠模型进行了评估.
- 转录组分析和西部斑点测试被用来探索SYR调节的信号通路.
主要成果:
- 在细胞和动物模型中,SYR治疗显著改善了肠道屏障完整性,减少了关键炎症标记物 (TNF-α,IL-6,IFN-γ,COX-2),并增强了紧结蛋白表达.
- 在DSS诱导的UC小鼠中,SYR的剂量取决于改善了临床结果,减少了炎症和细菌转移,并保留了结肠粘膜超结构.
- 转录组分析显示,SYR的抗UC作用通过PI3K-Akt/MAPK/Wnt信号通路进行介导.
结论:
- 通过加强肠上皮质屏障功能和抑制炎症反应,SYR有效地减轻UC的发展.
- 天然素SYR为治疗性结肠炎提供了一个有前途的治疗候选者.
更多相关视频
09:11Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
06:31Author Spotlight: Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids
Published on: June 2, 2023
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Renewal of Intestinal Stem Cells
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
